Logo image of CENX

CENTURY ALUMINUM COMPANY (CENX) Stock Fundamental Analysis

NASDAQ:CENX - Nasdaq - US1564311082 - Common Stock - Currency: USD

16.02  +0.83 (+5.46%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CENX. CENX was compared to 152 industry peers in the Metals & Mining industry. There are concerns on the financial health of CENX while its profitability can be described as average. CENX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

CENX had positive earnings in the past year.
In the past year CENX has reported a negative cash flow from operations.
In the past 5 years CENX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CENX reported negative operating cash flow in multiple years.
CENX Yearly Net Income VS EBIT VS OCF VS FCFCENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

CENX's Return On Assets of 16.43% is amongst the best of the industry. CENX outperforms 95.39% of its industry peers.
CENX has a Return On Equity of 45.90%. This is amongst the best in the industry. CENX outperforms 98.03% of its industry peers.
CENX has a better Return On Invested Capital (6.46%) than 68.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CENX is significantly below the industry average of 8.61%.
The 3 year average ROIC (3.18%) for CENX is below the current ROIC(6.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.43%
ROE 45.9%
ROIC 6.46%
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
CENX Yearly ROA, ROE, ROICCENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CENX has a Profit Margin of 14.35%. This is amongst the best in the industry. CENX outperforms 83.55% of its industry peers.
CENX has a Operating Margin of 5.47%. This is comparable to the rest of the industry: CENX outperforms 58.55% of its industry peers.
In the last couple of years the Operating Margin of CENX has grown nicely.
With a Gross Margin value of 8.33%, CENX is not doing good in the industry: 61.18% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CENX has grown nicely.
Industry RankSector Rank
OM 5.47%
PM (TTM) 14.35%
GM 8.33%
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
CENX Yearly Profit, Operating, Gross MarginsCENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CENX is destroying value.
The number of shares outstanding for CENX has been increased compared to 1 year ago.
Compared to 5 years ago, CENX has more shares outstanding
The debt/assets ratio for CENX is higher compared to a year ago.
CENX Yearly Shares OutstandingCENX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CENX Yearly Total Debt VS Total AssetsCENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CENX has an Altman-Z score of 1.03. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
CENX's Altman-Z score of 1.03 is on the low side compared to the rest of the industry. CENX is outperformed by 71.05% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that CENX is somewhat dependend on debt financing.
CENX has a worse Debt to Equity ratio (0.67) than 81.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACC0.63
WACC10.22%
CENX Yearly LT Debt VS Equity VS FCFCENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.73 indicates that CENX should not have too much problems paying its short term obligations.
CENX has a Current ratio of 1.73. This is in the lower half of the industry: CENX underperforms 62.50% of its industry peers.
A Quick Ratio of 0.57 indicates that CENX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.57, CENX is doing worse than 84.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.57
CENX Yearly Current Assets VS Current LiabilitesCENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 254.84% over the past year.
The Revenue has been growing slightly by 1.60% in the past year.
The Revenue has been growing slightly by 3.87% on average over the past years.
EPS 1Y (TTM)254.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.64%
Revenue 1Y (TTM)1.6%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%23.17%

3.2 Future

The Earnings Per Share is expected to grow by 62.41% on average over the next years. This is a very strong growth
CENX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.44% yearly.
EPS Next Y188.85%
EPS Next 2Y48.09%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue Next Year12.35%
Revenue Next 2Y9.33%
Revenue Next 3Y10.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CENX Yearly Revenue VS EstimatesCENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CENX Yearly EPS VS EstimatesCENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.56, which indicates a correct valuation of CENX.
CENX's Price/Earnings ratio is rather cheap when compared to the industry. CENX is cheaper than 86.18% of the companies in the same industry.
When comparing the Price/Earnings ratio of CENX to the average of the S&P500 Index (27.63), we can say CENX is valued slightly cheaper.
A Price/Forward Earnings ratio of 5.04 indicates a rather cheap valuation of CENX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CENX indicates a rather cheap valuation: CENX is cheaper than 99.34% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CENX to the average of the S&P500 Index (20.85), we can say CENX is valued rather cheaply.
Industry RankSector Rank
PE 14.56
Fwd PE 5.04
CENX Price Earnings VS Forward Price EarningsCENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

66.45% of the companies in the same industry are more expensive than CENX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.3
CENX Per share dataCENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX's earnings are expected to grow with 62.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y48.09%
EPS Next 3Y62.41%

More info and screens

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (4/22/2025, 2:10:50 PM)

16.02

+0.83 (+5.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners58.39%
Inst Owner Change0.04%
Ins Owners1.08%
Ins Owner Change0.29%
Market Cap1.48B
Analysts84.44
Price Target25.84 (61.3%)
Short Float %9.98%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.28%
Min EPS beat(2)7.95%
Max EPS beat(2)124.6%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.36%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)20.06%
Revenue beat(4)2
Avg Revenue beat(4)6.75%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)20.06%
Revenue beat(8)6
Avg Revenue beat(8)6.86%
Revenue beat(12)7
Avg Revenue beat(12)3.73%
Revenue beat(16)7
Avg Revenue beat(16)1.6%
PT rev (1m)1.33%
PT rev (3m)10.14%
EPS NQ rev (1m)-0.89%
EPS NQ rev (3m)38.75%
EPS NY rev (1m)51.58%
EPS NY rev (3m)76.49%
Revenue NQ rev (1m)-4.08%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.31%
Revenue NY rev (3m)1.22%
Valuation
Industry RankSector Rank
PE 14.56
Fwd PE 5.04
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 2.13
P/tB 2.13
EV/EBITDA 9.3
EPS(TTM)1.1
EY6.87%
EPS(NY)3.18
Fwd EY19.83%
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS24.06
BVpS7.52
TBVpS7.52
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.43%
ROE 45.9%
ROCE 8.23%
ROIC 6.46%
ROICexc 6.61%
ROICexgc 6.61%
OM 5.47%
PM (TTM) 14.35%
GM 8.33%
FCFM N/A
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)3.31%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y6.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.18%
ROICexc growth 5YN/A
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 2.29
Cap/Depr 100.61%
Cap/Sales 3.71%
Interest Coverage 3.37
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.57
Altman-Z 1.03
F-Score4
WACC10.22%
ROIC/WACC0.63
Cap/Depr(3y)115.12%
Cap/Depr(5y)92.4%
Cap/Sales(3y)3.72%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)254.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.64%
EPS Next Y188.85%
EPS Next 2Y48.09%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue 1Y (TTM)1.6%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%23.17%
Revenue Next Year12.35%
Revenue Next 2Y9.33%
Revenue Next 3Y10.44%
Revenue Next 5YN/A
EBIT growth 1Y287.86%
EBIT growth 3Y20.15%
EBIT growth 5YN/A
EBIT Next Year248.74%
EBIT Next 3Y66.3%
EBIT Next 5YN/A
FCF growth 1Y-1108.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.29%
OCF growth 3YN/A
OCF growth 5YN/A